Literature DB >> 194772

Effect of carbamazepine on the in vitro uptake and release of norepinephrine in adrenergic nerves of rabbit aorta and in whole brain synaptosomes.

R E Purdy, R M Julien, A S Fairhurst, M D Terry.   

Abstract

The effects of carbamazepine, in vitro, on adrenergic neuronal and whole brain synaptosomal uptake and release of tritiated norepinephrine (3H-NE) were assessed. At 10(-4) M, carbamazepine inhibited 3H-NE uptake by 22% in rabbit thoracic aorta and in brain synaptosomes. At the same concentration, carbamazepine inhibited stimulation-induced release of 3H-NE by 42.6% and inhibited isometric contraction in rabbit ear artery helical strips by 31.6%. At 10(-5) M, carbamazepine exhibited a 17.6% inhibition of 3H-NE uptake in brain synaptosomes in the absence of effects on transmitter release. Cocaine, 10(-4) M, and imipramine, 10(-4) M, inhibited uptake by 88% and 85%, respectively, in aorta, and cocaine, 10(-4) M, inhibited synaptosomal uptake by 67.7%. Since antiepileptic blood levels of carbamazepine range between 1.3 and 3.0 X 10(-5) M, it was concluded that the observed effects of carbamazepine are insufficient to account for the anticonvulsant action of the drug. However, the blockade of 3H-NE uptake by brain synaptosomes at 10(-5) M serves to explain the recently described analeptic activity of this agent.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194772     DOI: 10.1111/j.1528-1157.1977.tb04474.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  10 in total

1.  The effects of carbamazepine on two animal models of depression.

Authors:  H M Barros; J R Leite
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 2.  Mechanisms of anticonvulsant drug action. I. Drugs primarily used for generalized tonic-clonic and partial epilepsies.

Authors:  C L Faingold; R A Browning
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

3.  Effects of carbamazepine and anti-depressant drugs on endogenous catecholamine levels in the cerebroventricular compartment of the rat.

Authors:  S Kowalik; M Levitt; A I Barkai
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Neuronal monoamine reuptake inhibitors enhance in vitro susceptibility to chloroquine in resistant Plasmodium falciparum.

Authors:  A F Coutaux; J J Mooney; D F Wirth
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

5.  Inhibition by carbamazepine of various ion channels-mediated catecholamine secretion in cultured bovine adrenal medullary cells.

Authors:  R Yoshimura; N Yanagihara; T Terao; K Minami; K Abe; F Izumi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-09       Impact factor: 3.000

6.  Anxiolytic effect of carbamazepine in the elevated plus-maze: possible role of adenosine.

Authors:  H Zangrossi; J R Leite; F G Graeff
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine.

Authors:  M H Baf; M N Subhash; K M Lakshmana; B S Rao
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

8.  Effects of carbamazepine on noradrenergic mechanisms in affectively ill patients.

Authors:  R M Post; D R Rubinow; T W Uhde; J C Ballenger; C R Lake; M Linnoila; D C Jimerson; V Reus
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Cocaine Reduces Ciliary Beat Frequency of Human Nasal Epithelial Cells.

Authors:  Alexander Nastev; J Ulrich Sommer; Wieland Behr; Boris A Stuck; C Emika Mueller; Angela Schell; Benedikt Kramer; Daniel Haeussler; Karl Hoermann; Richard Birk
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

Review 10.  Carbamazepine toxicity and poisoning. Incidence, clinical features and management.

Authors:  L Durelli; U Massazza; R Cavallo
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.